RSS

tau aggregates

700 Alzheimer's patients have now been recruited for TauRx's latest phase of clinical trials. Read more

News

The posters will highlight recent cell and animal studies showing that a compound selected by Oligomerix's proprietary technology platform can reduce pathological tau aggregates. Read more